Almex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.22 M
- Company Age 34 Year, 10 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 1.14 Cr
About Almex Laboratories
Almex Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 1990 and has a history of 34 years and ten months. Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.22 M.
The company currently has active open charges totaling ₹1.14 Cr.
Aparna Save, Ajit Save, and Aniket Save serve as directors at the Company.
Company Details
- Location Mumbai, Maharashtra
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1990PTC056126
-
Company No.
056126
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Apr 1990
-
Date of AGM
26 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Almex Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aparna Save
|
Director | 10-Apr-1990 | Current |
|
Ajit Save
|
Whole-Time Director | 18-Mar-1993 | Current |
|
Aniket Save
|
Additional Director | 01-Sep-2011 | Current |
Financial Performance of Almex Laboratories.
Enhance accessibility to Almex Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Almex Laboratories?
Unlock access to Almex Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹11.38 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
- Bank Of Maharashtra : 0.50 Cr
- Centurion Bank Of Punjab : 0.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2017 | Others | ₹5.00 M | Open |
| 03 Oct 2012 | Bank Of Maharashtra | ₹5.00 M | Open |
| 02 Dec 2005 | Centurion Bank Of Punjab | ₹1.38 M | Open |
How Many Employees Work at Almex Laboratories?
Unlock and access historical data on people associated with Almex Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Almex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
